ORMD-0801
Phase 3UNKNOWN 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus, Type 2
Conditions
Diabetes Mellitus, Type 2
Trial Timeline
Oct 1, 2021 → Jul 1, 2022
NCT ID
NCT04817215About ORMD-0801
ORMD-0801 is a phase 3 stage product being developed by Oramed Pharmaceuticals for Diabetes Mellitus, Type 2. The current trial status is unknown. This product is registered under clinical trial identifier NCT04817215. Target conditions include Diabetes Mellitus, Type 2.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes Mellitus, Type 2 were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
17
Activity
4
Company
5
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04817215 | Phase 3 | UNKNOWN |
| NCT04754334 | Phase 3 | Terminated |
| NCT04564846 | Phase 2 | Completed |
Competing Products
20 competing products in Diabetes Mellitus, Type 2